BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22936589)

  • 1. Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer.
    Ishibashi K; Ishida H; Ohsawa T; Okada N; Kumamoto K; Haga N
    Tech Coloproctol; 2013 Feb; 17(1):51-7. PubMed ID: 22936589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer.
    Ishida H; Ishibashi K; Ohsawa T; Okada N; Kumamoto K; Haga N
    Int Surg; 2011; 96(4):291-9. PubMed ID: 22808609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.
    Suzuki H; Fujii T; Asao T; Tsutsumi S; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
    World J Surg; 2014 Aug; 38(8):2079-88. PubMed ID: 24615606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.
    Liu W; Yan XL; Wang K; Bao Q; Sun Y; Xing BC
    Int J Colorectal Dis; 2014 Jun; 29(6):737-45. PubMed ID: 24743847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
    Cardona K; Mastrodomenico P; D'Amico F; Shia J; Gönen M; Weiser MR; Paty PB; Kingham TP; Allen PJ; De Matteo RP; Fong Y; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2013 Jan; 20(1):148-54. PubMed ID: 22847127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.
    Thomay AA; Nagorney DM; Cohen SJ; Sigurdson ER; Truty MJ; Burtness B; Hall MJ; Chun YS
    J Gastrointest Surg; 2014 Jan; 18(1):69-74. PubMed ID: 24002765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of Hepatic Lymph Node Involvement in Patients with Resectable Liver Metastasis of Colorectal Cancer after Preoperative Chemotherapy].
    Ogura T; Muta Y; Hatano S; Amano K; Ishiguro T; Fukuchi M; Inokuma S; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):339-341. PubMed ID: 29483440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.
    Nanji S; Cleary S; Ryan P; Guindi M; Selvarajah S; Al-Ali H; Grieg P; McGilvary I; Taylor B; Wei A; Moulton CA; Gallinger S
    Ann Surg Oncol; 2013 Jan; 20(1):295-304. PubMed ID: 23054102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
    Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
    J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of synchronous liver metastases from colorectal cancer.
    Fujita S; Akasu T; Moriya Y
    Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis.
    Faron M; Chirica M; Tranchard H; Balladur P; de Gramont A; Afchain P; Andre T; Paye F
    J Gastrointest Cancer; 2014 Sep; 45(3):298-306. PubMed ID: 24610400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases.
    Galizia G; Lieto E; Orditura M; Castellano P; Imperatore V; Pinto M; Zamboli A
    Arch Surg; 2008 Apr; 143(4):352-8; discussion 358. PubMed ID: 18427022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].
    Wang Z; Zhou ZX; Liang JW; Bai XF; Bi JJ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):372-5. PubMed ID: 18953839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
    Miyanari N; Mori T; Takahashi K; Yasuno M
    Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.